tiprankstipranks
Xbrane Biopharma AB (DE:7XB)
:7XB
Germany Market
Holding DE:7XB?
Track your performance easily

Xbrane Biopharma AB (7XB) Financial Statements

2 Followers

Xbrane Biopharma AB Financial Overview

Xbrane Biopharma AB's market cap is currently ―. The company's EPS TTM is €-0.085; its P/E ratio is ―; Xbrane Biopharma AB is scheduled to report earnings on February 21, 2025, and the estimated EPS forecast is €<0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 20.86M$ 13.94M$ 15.63M$ 7.19M$ 11.53M
Gross Profit$ 20.86M$ 13.94M$ 15.63M$ 7.19M$ 11.53M
EBIT$ -54.76M$ -41.99M$ -32.40M$ -36.78M$ -32.15M
EBITDA$ -54.76M$ -41.99M$ -32.40M$ -36.78M$ -32.15M
Net Income Common Stockholders$ -60.73M$ -41.88M$ -33.77M$ -36.12M$ -32.47M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 193.99M$ 165.24M$ 250.09M$ 301.46M$ 295.18M
Total Assets$ 690.51M$ 582.46M$ 683.70M$ 675.73M$ 688.43M
Total Debt$ 38.22M$ 40.43M$ 42.60M$ 42.45M$ 44.38M
Net Debt$ -155.77M$ -124.81M$ -207.48M$ -259.01M$ -250.80M
Total Liabilities$ 265.63M$ 255.70M$ 317.96M$ 279.48M$ 256.69M
Stockholders Equity$ 424.89M$ 326.76M$ 365.73M$ 396.25M$ 431.74M
Cash Flow-
Free Cash Flow$ -124.46M$ -86.33M$ -57.14M$ 13.89M$ -86.27M
Operating Cash Flow$ -115.06M$ -74.88M$ -49.45M$ 45.47M$ -60.37M
Investing Cash Flow$ -9.41M$ -11.46M$ -7.69M$ -31.58M$ -25.90M
Financing Cash Flow$ 154.97M$ -2.17M$ -2.00M$ -1.93M$ -2.34M
Currency in USD

Xbrane Biopharma AB Earnings and Revenue History

Xbrane Biopharma AB Debt to Assets

Xbrane Biopharma AB Cash Flow

Xbrane Biopharma AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis